by MM360 Staff | Jun 6, 2025 | Publications
Clin Lymphoma Myeloma Leuk. 2025 May 14:S2152-2650(25)00159-4. doi: 10.1016/j.clml.2025.05.007. Online ahead of print. ABSTRACT BACKGROUND: The standard treatment for newly diagnosed, transplant-eligible multiple myeloma (NDMM) patients typically involves triplet...
by MM360 Staff | Jun 5, 2025 | Myeloma News
Source: Pharmacy Times articles Pharmacists navigate reimbursement challenges while advocating for legislative support and innovative models to enhance patient care and financial sustainability. Read More
by MM360 Staff | Jun 5, 2025 | Uncategorized
Source: CureToday articles Katherine has an exquisite instinct for understanding that there is a context to each patient’s diagnosis that is just as important to understand. Read More
by MM360 Staff | Jun 5, 2025 | Uncategorized
Source: CureToday articles Natalie Schnaitmann discusses urgent supportive care gaps younger women with cancer encounter, and how they affect long-term quality of life. Read More
by MM360 Staff | Jun 5, 2025 | Myeloma News
Source: Pharmacy Times articles Compared with standard of care, camizestrant in combination with a CDK4/6 inhibitor shows promise in enhancing progression-free survival (PFS) for patients with advanced breast cancer. Read More
